MedPath

Physiological Effects of High-Flow Tracheal Oxygen Via An Modified Interface

Completed
Conditions
Tracheostomy
Interventions
Procedure: The modified HFT
Registration Number
NCT03244761
Lead Sponsor
Capital Medical University
Brief Summary

Tracheostomy is often performed in patients after or anticipated prolonged mechanical ventilation, who are usually required oxygen therapy after discontinuation of mechanical ventilation.

Detailed Description

Tracheostomy is often performed in patients after or anticipated prolonged mechanical ventilation, who are usually required oxygen therapy after discontinuation of mechanical ventilation.The high-flow tracheal (HFT) oxygen therapy in tracheostomized patients has been shown that can improve oxygenation,but can not induce positive end-expiratory pressure and elevation of end-expiratory lung volume. A modified HFT system by increasing expiratory resistance might induce PEEP and consequently elevate EELV.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • The tracheostomized patient requiring the convenient oxygen therapy.
Exclusion Criteria
  • Under 18 years;
  • history of esophageal, gastric or lung surgery;
  • The contraindication of using EIT (pacemaker, defibrillator, and implantable pumps).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
The modified HFTThe modified HFTThe high-flow oxygen was delivered via tracheostomy using a modified HFT.
Primary Outcome Measures
NameTimeMethod
The mean end expiratory pressure.the last 1 minutes of steady breathing during the standard or modified HFT.

The patients was delivering the high flow oxygen via the standard and modified HFT interface for 20 minutes.

Secondary Outcome Measures
NameTimeMethod
Changes in global and regional EELVthe last 1 minutes of steady breathing during the standard or modified HFT.

The Electrical impedance tomography (EIT) was applied in monitoring the change of EELV at the bedside.

Trial Locations

Locations (1)

Jian-Xin Zhou

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath